Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1440

Article ID: 696565

Why the eye could be the window to brain degeneration such as Alzheimer’s disease

Queen's University Belfast

Researchers from Queen’s University Belfast have shown that the eye could be a surrogate for brain degeneration like Alzheimer’s disease (AD).

Released:
25-Jun-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    21-Jun-2018 11:00 AM EDT

Article ID: 695954

Unusually High Levels of Herpesviruses Found in the Alzheimer’s Disease Brain

Mount Sinai Health System

Two strains of human herpesvirus—human herpesvirus 6A (HHV-6A) and human herpesvirus 7 (HHV-7) —are found in the brains of people with Alzheimer’s disease at levels up to twice as high as in those without Alzheimer’s, researchers from the Icahn School of Medicine at Mount Sinai report.

Released:
14-Jun-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696439

Alzheimer’s breakthrough: brain metals that may drive disease progression revealed

University of Warwick

Alzheimer’s disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.Dr Joanna Collingwood, from Warwick’s School of Engineering, was part of a research team which characterised iron species associated with the formation of amyloid protein plaques in the human brain – abnormal clusters of proteins in the brain.

Released:
21-Jun-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Andres_Lozano.JPG

Article ID: 696293

Deep Brain Stimulation showing promise for patients with mild Alzheimer’s disease over age 65

University Health Network (UHN)

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 – 24 months) of the Phase II trial.

Released:
20-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695888

Is it Alzheimer’s? Maybe not. Three treatable conditions can cause memory loss

University of California, Los Angeles (UCLA), Health Sciences

When seniors experience memory problems, they may start worrying that they have Alzheimer’s disease. Indeed, Alzheimer’s is the most common cause of memory loss in the elderly – but sometimes an entirely different diagnosis is to blame.

Released:
8-Jun-2018 8:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695858

Wayne State researchers examine the role of glutamate in aging cognitive diseases

Wayne State University Division of Research

A research team at Wayne State University hopes to give clinicians tools for identifying the early signs of impending disease by measuring subtle deviations in the way the brain modulates its chemistry during the formation of new memories. Their research project, “Task-related modulation of hippocampal glutamate, subfield volumes and associative memory in younger and older adults: a longitudinal ¹H FMRS study,” was recently awarded a two-year, $423,500 grant from the National Institute on Aging of the National Institutes of Health.

Released:
8-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
AlzheimersResearch.jpg

Article ID: 695706

Alzheimer’s Foundation of America Grant to Stony Brook Medicine to Investigate Development of More Targeted Treatment

Stony Brook Medicine

The Alzheimer’s Foundation of America (AFA) is awarding $206,184 over the next three years to Stony Brook Medicine to support an innovative Positron Emission Tomography (PET) imaging research project that will compare neurons from healthy controls and those with Alzheimer’s disease in an effort to improve drug development.

Released:
6-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695605

Antimicrobials and Colon Effects, Copper and Alzheimer’s Disease, and More Featured in June 2018 Toxicological Sciences

Society of Toxicology

Copper exposure’s link Alzheimer’s disease, the effects of consumer microbials on the colon, a potential prostate-based activation of a carcinogen in cooked meat, and the impact of hydraulic fracturing mixtures on the immune system featured in latest issue of Toxicological Sciences.

Released:
5-Jun-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695530

How Does Alcohol Influence the Development of Alzheimer’s Disease?

University of Illinois at Chicago

Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta — the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer’s disease.

Released:
4-Jun-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
galvin-myths-facts.jpg

Article ID: 695474

Leading Neuroscientist Responds to Common Myths About Alzheimer’s Disease

Florida Atlantic University

Approximately 47 million people worldwide are living with Alzheimer’s disease (AD) and other dementias. One of the most prominent neuroscientists in the country has developed eight myths and truths about AD to shed light on this form of dementia that causes problems with memory, thinking and behavior.

Released:
4-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1440





Chat now!